EMA Authorised: Silodyx (silodosin) — Recordati Ireland Ltd

View source ↗

Summary

The European Medicines Agency authorised Silodyx (silodosin) by Recordati Ireland Ltd for the treatment of benign prostatic hyperplasia. EU authorization was gr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Silodyx (silodosin)

Snippet

Status: Authorised. Therapeutic area: Prostatic Hyperplasia. MAH: Recordati Ireland Ltd. Decision date: 10/02/2025